XML 43 R24.htm IDEA: XBRL DOCUMENT
v3.21.2

Collaborative Research and License Agreements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Research and Development [Abstract] |
Balance Of The Company's Contract Liability | The following table presents changes in the balances of the Company’s contract liabilities (in thousands):
|  | Deferred Revenue Balance at January 1, 2021 |  | Additions |  | Revenue (Recognized) Reversed |  | Deferred Revenue Balance at September 30, 2021
Ipsen Collaboration Agreement |  | $ | — |  |  | $ | 20,000 |  |  | $ | (803) |  |  | $ | 19,197 |
AbbVie Collaboration Agreement |  | $ | 8,343 |  |  | $ | — |  |  | $ | 3,404 |  |  | $ | 11,747 |
Total |  | $ | 8,343 |  |  | $ | 20,000 |  |  | $ | 2,601 |  |  | $ | 30,944 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration